Dr. Vinay Prasad is resuming leadership of the FDA center that regulates vaccines and biotech therapies, a spokesperson for ...

Dr. Vinay Prasad has been reinstated as the FDA's top vaccine regulator after resigning due to pressure from biotech executives and Trump allies. Known for his critical stance on drug approvals, ...

Robby Soave and Lindsey Granger discuss the rehiring of Vinay Prasad as FDA top vaccine regulator. #vinayprasad #fda ...

Vinay Prasad, MD, former head of the FDA’s vaccine and gene therapy division who resigned under political pressure two weeks ago, is returning to the agency, The New York Times reported Aug. 9. Dr.

President Donald Trump said Monday he’s placing the Washington, D.C., police department under federal control and deploying the National Guard to make the nation’s capital safer. Trump has ...

Vinay K. Prasad, MD, MPH, a controversial hematologist-oncologist who abruptly left his two leadership roles at FDA last ...

Today, we discuss lots of government maneuvering that impacts biopharma — starting, of course, with the FDA reinstating Vinay ...

Key Takeaways Vinay Prasad is returning as head of the FDA’s Center for Biologics Evaluation and ResearchHe was reportedly ...

The shares of biotech companies fell after news that ousted regulator Vinay Prasad is set to go back to the US Food and Drug Administration.Prasad had previously overruled his own scientific review ...

Note that some links may require registration or subscription. DermaRite Industries is recalling certain lots of its over-the ...

Plus more pharma news from the Pharmalittle newsletter.

Vinay Prasad returns as FDA's CBER director after brief exit, raising questions on rare disease drug approvals and mRNA ...